Graft Polymer (UK) (LSE:GPL) Total Long-Term Assets : £2.07 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Graft Polymer (UK) Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Graft Polymer (UK)'s Total Long-Term Assets for the quarter that ended in Jun. 2024 was £2.07 Mil.

Graft Polymer (UK) Total Long-Term Assets Historical Data

The historical data trend for Graft Polymer (UK)'s Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Graft Polymer (UK) Total Long-Term Assets Chart

Graft Polymer (UK) Annual Data

Trend

May18

May19

May20

May21

Dec22

Dec23

Total Long-Term Assets

Get a 7-Day Free Trial

2.66

2.56

2.44

2.78

2.12

Graft Polymer (UK) Semi-Annual Data
	May18	May19	May20	May21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Long-Term Assets	Get a 7-Day Free Trial				2.41	2.78	2.93	2.12	2.07

Graft Polymer (UK) Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Graft Polymer (UK) Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Graft Polymer (UK)'s Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Graft Polymer (UK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Graft Polymer (UK) PLC (LSE:GPL) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF

Website

https://www.graftpolymer.com

Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.

Graft Polymer (UK) Headlines

No Headlines